Combination of Endoglin and ASCVD Risk Assessment Improves Carotid Subclinical Atherosclerosis Recognition

Aim: Our study investigated the association between soluble endoglin and carotid subclinical atherosclerosis. Methods: We used endoglin as an adjunct to atherosclerotic cardiovascular disease (ASCVD) risk, in recognition of carotid clinical atherosclerosis, in order to explore a new model to refine...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiaowei, Lin, Fan, Ke, Douli, Cheng, Qiong, Gui, Yongzhi, Zhou, Yuyan, Wu, Yicheng, Wang, Yinzhou, Zhu, Pengli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192815/
https://www.ncbi.nlm.nih.gov/pubmed/31406054
http://dx.doi.org/10.5551/jat.50898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192815/
https://www.ncbi.nlm.nih.gov/pubmed/31406054
http://dx.doi.org/10.5551/jat.50898

Ejemplares similares